Dr. Gibran Hamid Mahmud, MD

Dr. Mahmud practices at Oakview Heights Cont. Care & Rehab in Glen Carbon, Illinois.

Dr. Mahmud's NPI, 1518132489, was assigned on April 23, 2008. Dr. Mahmud holds Missouri license 2011020105.

Dr. Mahmud's primary practice is Oakview Heights Cont. Care & Rehab, at 4215 State Rte 159, Glen Carbon, IL 62034 in Madison County. The practice phone is (618) 263-4337.

Dr. Mahmud's primary practice is Oakview Heights Cont. Care & Rehab in Glen Carbon, Illinois. Dr. Mahmud is also affiliated with HSHS St. Elizabeth's Hospital. The medical group on file is Cancer Care Specialists of IL. Dmand AI also links Dr. Mahmud to 4 more hospitals, 1 group practice or clinic, 1 hospice and 1 skilled nursing facility, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mahmud practices, 8 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Mahmud's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Mahmud is licensed in Missouri.

CMS data shows 366,882 Medicare services from Dr. Mahmud across 85 procedure codes in 2024, for 991 Medicare patients. Medicare paid $2,994,009 for them.

CMS counts 991 Medicare patients who saw Dr. Mahmud in 2024. The largest group is 65 to 74, with 385 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 25% are also on Medicaid. Their average risk score is 1.87, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mahmud's median patient age at 74, with 60% women.

In 2024, Dr. Mahmud wrote 2,787 Medicare Part D claims for 399 patients. 80% of them were for generic drugs. CMS names the drug for 2,444 of them, across 60 drugs with 11 or more claims each, at $4,808,222 in total drug cost. In 2023, CMS named 2,320 claims across 65 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Mahmud for performance year 2024, reported as part of a group. Dr. Mahmud accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mahmud as offering telehealth.

Dmand AI links 2 papers to Dr. Mahmud, published from 2013 to 2014. Dr. Mahmud's most frequent co-authors are Mark Joseph Fesler, MD and Bahar Bastani, MD.

CMS Open Payments shows 1,534 general payments to Dr. Mahmud from 78 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Novartis Pharmaceuticals Corporation paid the most, $3,021.